FMX Stock Analysis: Fomento Economico Mexicano | NYSE
Beverages - Brewers | NYSE, USA | Market Cap: 44.050m USD | 12M Return: 33.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 69.5M
EPS Trend: -55.4%
Qual. Beats: -1
Rev. Trend: -84.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Fomento Económico Mexicano (FEMSA) is a Mexican multinational operating as a Coca-Cola franchise bottler and a diversified retail conglomerate headquartered in Monterrey, Mexico. Its beverage arm produces, markets, and distributes Coca-Cola trademark products across Latin America, including Mexico, Brazil, Argentina, and several Central and South American countries.
Beyond beverages, FEMSA operates the OXXO small-box convenience store chain in Mexico, Colombia, Peru, Chile, Brazil, and the United States, making it one of the largest convenience store operators in Latin America by store count. The company also runs OXXO GAS fuel retail stations in Mexico, a portfolio of drugstore brands in Chile, Colombia, Ecuador, and Mexico, electronic payment processing services for small and medium-sized businesses, and European small-box retail and foodvenience chains across Switzerland, Germany, Austria, Luxembourg, and the Netherlands. This diversified structure spreads revenue across multiple consumer staples categories, reducing dependence on any single business line.
Founded in 1890 and listed on the NYSE since 1998, FEMSA is classified within the Consumer Staples sector, with bottling franchises and convenience retail representing the core of its long-standing business model.
- OXXO same-store sales growth and new store expansion across Latin America
- Coca-Cola FEMSA pricing offsets sugar and aluminum input cost inflation
- Mexican peso depreciation pressures USD-translated revenue and margins
| Net Income: 1.59b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -8.24 > 1.0 |
| NWC/Revenue: 4.31% < 20% (prev 1.52%; Δ 2.79% < -1%) |
| CFO/TA 0.11 > 3% & CFO 4.76b > Net Income 1.59b |
| Net Debt (246b) to EBITDA (6.72b): 36.61 < 3 |
| Current Ratio: 1.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (335.1m) vs 12m ago -3.44% < -2% |
| Gross Margin: 40.66% > 18% (prev 40.96%; Δ -0.31% > 0.5%) |
| Asset Turnover: 108.7% > 50% (prev 999.9%; Δ -891.2% > 0%) |
| Interest Coverage Ratio: 3.94 > 6 (EBIT TTM 4.04b / Interest Expense TTM 1.03b) |
| A: 0.05 (Total Current Assets 14.9b - Total Current Liabilities 12.9b) / Total Assets 44.4b |
| B: 0.32 (Retained Earnings 14.0b / Total Assets 44.4b) |
| C: 0.09 (EBIT TTM 4.04b / Avg Total Assets 43.0b) |
| D: 0.42 (Book Value of Equity 11.8b / Total Liabilities 28.1b) |
| Altman-Z'' = 2.40 = A |
| DSRI: 3.0 (Receivables 2.45b/2.03b, Revenue 46.7b/415b) |
| GMI: 1.01 (GM 40.96% / 40.66%) |
| AQI: 1.04 (AQ_t 0.29 / AQ_t-1 0.28) |
| SGI: 0.11 (Revenue 46.7b / 415b) |
| TATA: -0.07 (NI 1.59b - CFO 4.76b) / TA 44.4b) |
| Beneish M = -1.99 (Cap -4..+1) = B |
As of July 07, 2026, the stock is trading at USD 130.25 with a total of 447,781 shares traded. Over the past week, the price has changed by +1.07%, over one month by +6.32%, over three months by +16.32% and over the past year by +33.17%.
Current recommended Stop Loss: 121.80 (which is 6.5% or 2.6 ATR below the current price).
Fomento Economico Mexicano has received a consensus analysts rating of 3.77. Therefore, it is recommended to hold FMX.
- StrongBuy: 3
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 126.7 | -2.7% |
P/E Trailing = 28.6696
P/E Forward = 99.0099
P/S = 0.0516
P/B = 3.676
P/EG = 5.2401
Revenue TTM = 46.7b USD
EBIT TTM = 4.04b USD
EBITDA TTM = 6.72b USD
Long Term Debt = 137b USD (from longTermDebt, last quarter)
Short Term Debt = 1.26b USD (from shortTermDebt, last quarter)
Debt = 252b USD (corrected: LT Debt 137b + ST Debt 1.26b) + Leases 114b
Net Debt = 246b USD (calculated: Debt 252b - CCE 6.41b)
Enterprise Value = 290b USD (44.1b + Debt 252b - CCE 6.41b)
Interest Coverage Ratio = 3.94 (Ebit TTM 4.04b / Interest Expense TTM 1.03b)
EV/FCF = 113.8x (Enterprise Value 290b / FCF TTM 2.55b)
FCF Yield = 0.88% (FCF TTM 2.55b / Enterprise Value 290b)
FCF Margin = 5.45% (FCF TTM 2.55b / Revenue TTM 46.7b)
Net Margin = 3.39% (Net Income TTM 1.59b / Revenue TTM 46.7b)
Gross Margin = 40.66% ((Revenue TTM 46.7b - Cost of Revenue TTM 27.7b) / Revenue TTM)
Gross Margin QoQ = 40.47% (prev 41.54%)
Tobins Q-Ratio = 6.53 (Enterprise Value 290b / Total Assets 44.4b)
Interest Expense / Debt = 0.41% (Interest Expense 1.03b / Debt 252b)
Taxrate = 30.34% (1.03b / 3.39b)
NOPAT = 2.82b (EBIT 4.04b * (1 - 30.34%))
Current Ratio = 1.16 (Total Current Assets 14.9b / Total Current Liabilities 12.9b)
Debt / Equity = 21.36 (Debt 252b / totalStockholderEquity, last quarter 11.8b)
Debt / EBITDA = 36.61 (Net Debt 246b / EBITDA 6.72b)
Debt / FCF = 96.51 (Net Debt 246b / FCF TTM 2.55b)
Total Stockholder Equity = 12.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.69% (Net Income 1.59b / Total Assets 44.4b)
RoE = 12.29% (Net Income TTM 1.59b / Total Stockholder Equity 12.9b)
RoCE = 2.69% (EBIT 4.04b / Capital Employed (Equity 12.9b + L.T.Debt 137b))
RoIC = 9.25% (NOPAT 2.82b / Invested Capital 30.4b)
WACC = 1.28% (E(44.1b)/V(296b) * Re(6.97%) + D(252b)/V(296b) * Rd(0.41%) * (1-Tc(0.30)))
Discount Rate = 6.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -68.03 | Cagr: -2.01%
[DCF] Terminal Value 73.10% ; FCFF base≈3.85b ; Y1≈3.38b ; Y5≈2.73b
[DCF] Fair Price = N/A (negative equity: EV 43.8b - Net Debt 246b = -202b; debt exceeds intrinsic value)
EPS Correlation: -55.44 | EPS CAGR: -17.21% | SUE: -4.0 | # QB: -1
Revenue Correlation: -84.42 | Revenue CAGR: -67.61% | SUE: -0.49 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.07 | Chg30d=-0.72% | Revisions=-17% | Analysts=4
EPS next Quarter (2026-09-30): EPS=1.11 | Chg30d=+0.30% | Revisions=-17% | Analysts=4
EPS current Year (2026-12-31): EPS=5.77 | Chg30d=-3.28% | Revisions=+57% | GrowthEPS=+101.8% | GrowthRev=+6.5%
EPS next Year (2027-12-31): EPS=5.35 | Chg30d=+1.15% | Revisions=-17% | GrowthEPS=-7.2% | GrowthRev=+7.8%
[Analyst] Revisions Ratio: +6% (up=7, down=6)